Oral glycopyrrolate for primary focal hyperhidrosis in a pediatric population: A cross-sectional study
- PMID: 34409395
- PMCID: PMC8361902
- DOI: 10.1016/j.jdin.2021.07.002
Oral glycopyrrolate for primary focal hyperhidrosis in a pediatric population: A cross-sectional study
Conflict of interest statement
None disclosed.
References
-
- Remington C., Ruth J., Hebert A.A. Primary hyperhidrosis in children: a review of therapeutics. Pediatr Dermatol. 2021;38(3):561–567. - PubMed
-
- Paller A.S., Shah P.R., Silverio A.M., Wagner A., Chamlin S.L., Mancini A.J. Oral glycopyrrolate as second-line treatment for primary pediatric hyperhidrosis. J Am Acad Dermatol. 2012;67(5):918–923. - PubMed
-
- Bahar R., Zhou P., Liu Y. The prevalence of anxiety and depression in patients with or without hyperhidrosis (HH) J Am Acad Dermatol. 2016;75(6):1126–1133. - PubMed
-
- Kumar M.G., Foreman R.S., Berk D.R., Bayliss S.J. Oral glycopyrrolate for refractory pediatric and adolescent hyperhidrosis. Pediatr Dermatol. 2014;31(1):e28–e30. - PubMed
LinkOut - more resources
Full Text Sources
